Bumrungrad Hospital Beheer

Beheer criteriumcontroles 2/4

De CEO Bumrungrad Hospital is Artirat Charukitpipat, benoemd in Apr2021, heeft een ambtstermijn van 3.5 jaar. bezit rechtstreeks 0.001% van de aandelen van het bedrijf, ter waarde THB 2.43M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.4 jaar en 11.5 jaar.

Belangrijke informatie

Artirat Charukitpipat

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.6yrs
Eigendom CEO	0.001%
Management gemiddelde ambtstermijn	5.5yrs
Gemiddelde ambtstermijn bestuur	11.6yrs

Recente managementupdates

Recent updates

CEO

Artirat Charukitpipat (56 yo)

3.6yrs

Tenure

Ms. Artirat Charukitpipat serves as Chief Executive Officer at Bumrungrad Hospital Public Company Limited since April 2021 and also served as Chief Executive Officer of Bumrungrad Hospital since January 31...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Linda Lisahapanya	President	no data	฿1.71m	0.0072% THB 15.5m
Artirat Charukitpipat	Chief Executive Officer	3.6yrs	geen gegevens	0.0011% THB 2.4m
Oraphan Buamuang	Chief Financial Officer	8.7yrs	geen gegevens	geen gegevens
Nipat Kulabkaw	Chief Operating Officer	no data	geen gegevens	geen gegevens
Supawan Sirinuntawit	Accounting Manager	4.2yrs	geen gegevens	geen gegevens
Daniel Kastner	Chief Transformation Office & Head of IR	no data	geen gegevens	geen gegevens
Aniello Sorrentino	Corporate Chief Strategy Officer	no data	geen gegevens	geen gegevens
David Boucher	Chief Business Transformation Officer	no data	geen gegevens	geen gegevens
Tanee Maneenut	Chief Business Development Officer	no data	geen gegevens	geen gegevens
Rangsima Thongdee	Head of Internal Audit	6.8yrs	geen gegevens	geen gegevens
Rajeev Rajan	Chief Business Development Officer-International Markets	no data	geen gegevens	geen gegevens
Jeremy Ford	Laboratory Research & Technology Director of Bumrungrad International Hospital	no data	geen gegevens	geen gegevens

5.5yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Linda Lisahapanya	President	12.6yrs	฿1.71m	0.0072% THB 15.5m
Charnwut Chan	Non-Executive Director	7.1yrs	฿1.71m	0.20% THB 429.2m
Sophavadee Uttamobol	Independent Director	13.6yrs	฿1.95m	geen gegevens
Chong Toh	Non-Executive Director	13.6yrs	฿1.83m	0.39% THB 851.4m
Chanvit Tanphiphat	Non-Executive Vice Chairman of the Board	11.6yrs	฿2.02m	0.060% THB 130.6m
Chai Sophonpanich	Non-Executive Chairman of the Board	no data	฿2.31m	1.3% THB 2.8b
Prin Chirathivat	Independent Director	12.6yrs	฿1.87m	0.0041% THB 8.9m
Chanida Sophonpanich	Non-Executive Director	less than a year	geen gegevens	geen gegevens
Aruni Kettratad	Independent Director	14.6yrs	฿1.88m	geen gegevens
Anon Vangvasu	Non-Executive Director	4.5yrs	฿1.71m	geen gegevens
Mark Schatten	Independent Director	3.6yrs	฿1.87m	0.00024% THB 518.9k
Chanond Sophonpanich	Independent Director	3.6yrs	฿1.87m	0.050% THB 108.8m

11.6yrs

Gemiddelde duur

66.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BH zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.5 jaar).

Bumrungrad Hospital Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Bumrungrad Hospital Public Company Limited Elects Chanida Sophonpanich as Non-Executive Director

Less than half of directors are independent

Less than half of directors are independent

Bumrungrad Hospital Public Company Limited, Annual General Meeting, Apr 28, 2021

Recent updates

Bumrungrad Hospital Public Company Limited Announces Cash Dividend for the Operating Period from 1 January 2024 to 30 June 2024, Payable on 6 September 2024

Bumrungrad Hospital Public Company Limited Announces Cash Dividend for the Operating Period from 1 January 2024 to 30 June 2024, Payable on 9 September 2024

Second quarter 2024 earnings released: EPS: ฿2.43 (vs ฿2.20 in 2Q 2023)

Now 14% overvalued after recent price rise

Now 21% overvalued after recent price rise

First quarter 2024 earnings released: EPS: ฿2.50 (vs ฿1.99 in 1Q 2023)

Bumrungrad Hospital Public Company Limited Elects Chanida Sophonpanich as Non-Executive Director

Upcoming dividend of ฿3.15 per share

Full year 2023 earnings released: EPS: ฿8.81 (vs ฿6.21 in FY 2022)

Bumrungrad Hospital Public Company Limited Proposes Payment of Dividend on ordinary shares for an Operating Period from 1 July 2023 to 31 December 2023, Payable on 10 May 2024

Bumrungrad Hospital Public Company Limited to Report Q3, 2024 Results on Nov 07, 2024

Third quarter 2023 earnings: EPS misses analyst expectations

Price target increased by 7.2% to ฿276

Price target increased by 7.2% to ฿274

Price target increased by 7.1% to ฿270

Upcoming dividend of ฿1.35 per share at 1.4% yield

Consensus EPS estimates increase by 14%

Second quarter 2023 earnings: EPS misses analyst expectations

Bumrungrad Hospital Public Company Limited Announces Cash Dividend for the Period Ended June 30, 2023, Payable on September 6, 2023

First quarter 2023 earnings released: EPS: ฿1.99 (vs ฿0.91 in 1Q 2022)

Upcoming dividend of ฿2.35 per share at 1.7% yield

Bumrungrad Hospital Public Company Limited to Report Q3, 2023 Results on Nov 09, 2023

Consensus EPS estimates increase by 20%

Third quarter 2022 earnings released: EPS: ฿1.89 (vs ฿0.37 in 3Q 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: ฿1.89 (vs ฿0.37 in 3Q 2021)

Investor sentiment improved over the past week

Price target increased to ฿203

Price target increased to ฿193

Consensus EPS estimates increase by 10%

Bumrungrad Hospital Public Company Limited Announces Interim Dividend for the Operating Period from January 1, 2022 to June 30, 2022, Payable on September 8, 2022

Consensus EPS estimates increase by 12%

First quarter 2022 earnings: EPS misses analyst expectations

Less than half of directors are independent

Upcoming dividend of ฿2.05 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Bumrungrad Hospital Public Company Limited Proposes Dividend for Operating Period from 1 July 2021 to 31 December 2021, Payable on 10 May, 2022

Third quarter 2021 earnings released: EPS ฿0.37 (vs ฿0.28 in 3Q 2020)

Director Prin Chirathivat has joined 5th company board

Director Prin Chirathivat has joined 5th company board

Director Prin Chirathivat has joined 5th company board

Director Prin Chirathivat has joined 5th company board

Director Prin Chirathivat has joined 5th company board

Consensus forecasts updated

Upcoming dividend of ฿1.15 per share

Second quarter 2021 earnings released: EPS ฿0.28 (vs ฿0.056 in 2Q 2020)

Consensus EPS estimates fall to ฿2.31

First quarter 2021 earnings released: EPS ฿0.11 (vs ฿1.03 in 1Q 2020)

New 90-day high: ฿137

Analysts lower EPS estimates to ฿2.44

Full year 2020 earnings released: EPS ฿1.54 (vs ฿5.14 in FY 2019)

Revenue and earnings miss expectations

Bumrungrad Hospital Public Company Limited, Annual General Meeting, Apr 28, 2021

New 90-day high: ฿133

Analysts update estimates

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: ฿114

Market bids up stock over the past week

Analysts lower EPS estimates to ฿1.59

Third quarter 2020 earnings released: EPS ฿0.28

Revenue and earnings miss expectations

New 90-day low: ฿94.00

New 90-day low: ฿105

New 90-day low - ฿109

Earnings released

CEO

Tenure

Leiderschapsteam

Gemiddelde duur